Inflammation in Drug Discovery and Development--SRI's Seventh International Meeting.  20-21 February 2003, San Diego, USA.
Braddock
Martin
M
Disease Science Section, Discovery Biosciences Division, AstraZeneca plc, Loughborough, Leicestershire LE11 5RH, UK. martin.braddock@astrazeneca.com
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology*; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors; D010003:Osteoarthritis / Q000188:drug therapy; D019151:Peptide Library; D010600:Pharmacology / Q000639:trends*; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors; D048051:p38 Mitogen-Activated Protein Kinases
D000893:Anti-Inflammatory Agents; D019151:Peptide Library; D019707:Receptors, Chemokine; D011965:Receptors, Glucocorticoid; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases